Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR)

Inclusion Criteria:

• Informed consent/(assent - if applicable)

• Male or female subjects 6-11 years of age

• General good health

• A documented history of PAR to a relevant perennial allergen for a minimum of 12months

• Other criteria apply

Exclusion Criteria:

• Pregnancy, nursing, or plans to become pregnant or donate gametes

• Participation in any investigational drug study within the 30 days preceding theScreening Visit 1 (SV1)

• Previous participation in a BDP nasal aerosol study as a randomized subject

• A known hypersensitivity to any corticosteroid or any of the excipients in the studymedication formulation

• History of physical findings of nasal pathology, including nasal polyps or otherclinically significant respiratory tract malformations

• History of a respiratory infection or disorder within the 14 days preceding theScreening Visit 1 (SV1)

• Use of any prohibited concomitant medications within the prescribed (per protocol)withdrawal periods prior to the Screening Visit 1 (SV1)

• Other criteria apply

• Current smoker or current user of tobacco products at any time during the study;history of smoking or use of tobacco products within the past year